HE
EXAS

Henry Ellenbogen’s Exact Sciences EXAS Stock Holding History

Henry Ellenbogen’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-320,456
Closed -$42.2M – 60
2021
Q1 		$42.2M Sell
320,456
-150,726
-32% -$20.6M 0.36% 45
2020
Q4 		$62.4M Sell
471,182
-60,176
-11% -$7.28M 0.56% 41
2020
Q3 		$54.2M Sell
531,358
-634,834
-54% -$54.8M 0.6% 41
2020
Q2 		$101M Buy
1,166,192
+1,066,753
+1,073% +$85.2M 1.26% 30
2020
Q1 		$5.77M Buy
+99,439
New +$8.07M 0.12% 44

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Henry Ellenbogen's EXAS Position: Q2 2021 in Review

Henry Ellenbogen sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 320,456 shares — an estimated $42.2M sold.

Henry Ellenbogen first reported a position in EXAS in Q1 2020 and held it in 5 quarters. The position peaked at $101M in Q2 2020. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Henry Ellenbogen reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Henry Ellenbogen sold 320,456 Exact Sciences shares in Q2 2021, an estimated $42.2M.
  • Henry Ellenbogen first reported a position in Exact Sciences in Q1 2020 and held it in 5 quarters.
  • Henry Ellenbogen's Exact Sciences position peaked at $101M in Q2 2020.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Durable Capital Partners's 13F filing for Q2 2021, filed 13 Aug 2021.